That the old vector had a low transduction efficiency and as far as I can tell the current one has better titer and potency. Stability and durability are fine so far, for both vectors. If the patient had not been such a severe one, even the weaker vector could probably do better and longer. Think the "GT nightmare scenario" is possible insertional oncogenesis more than low transgene expression.
News 
Market Data 
Discover 
AI
